Clinical responses to prolonged treatment of persistent pulmonary hypertension of the newborn with low doses of inhaled nitric oxide
- 31 July 1993
- journal article
- Published by Elsevier BV in The Journal of Pediatrics
- Vol. 123 (1), 103-108
- https://doi.org/10.1016/s0022-3476(05)81551-3
Abstract
We studied the efficacy of low-dose nitric oxide inhalation in nine consecutive patients with severe persistent pulmonary hypertension of the newborn (PPHN) who were candidates for extracorporeal membrane oxygenation (ECMO). All patients had marked hypoxemia despite aggressive ventilator management and echocardiographic evidence of pulmonary hypertension. Associated diagnoses included meconium aspiration syndrome (3 patients), sepsis (3 patients), and congenital diaphragmatic hernia (2 patients). Infants were initially treated with inhaled nitric oxide at 20 ppm for 4 hours and then at 6 ppm for 20 hours. In all infants, oxygenation promptly improved (arterial/alveolar oxygen ratio, 0.077±0.016 at baseline vs 0.193±0.030 at 4 hours; p <0.001) without a decrease in systemic blood pressure. Sustained improvement in oxygenation was achieved in eight patients treated with inhaled nitric oxide for 24 hours at 6 ppm (arterial/alveolar oxygen ratio, 0.270±0.053 at 24 hours; p <0.001 vs baseline). One patient with overwhelming sepsis had an initial improvement of oxygenation with nitric oxide but required ECMO for multiorgan and cardiac dysfunction. We conclude that low doses of nitric oxide cause sustained clinical improvement in severe PPHN and may reduce the need for ECMO. However, immediate availability of ECMO is important in selected cases of PPHN complicated by severe systemic hemodynamic collapse.Keywords
This publication has 17 references indexed in Scilit:
- Low-dose inhalational nitric oxide in persistent pulmonary hypertension of the newbornThe Lancet, 1992
- Inhaled nitric oxide in persistent pulmonary hypertension of the newbornThe Lancet, 1992
- Cardiac performance in ECMO candidates: Echocardiographic predictors for ECMOJournal of Pediatric Surgery, 1992
- Inhaled Nitric Oxide A Selective Pulmonary Vasodilator of Heparin-Protamine Vasoconstriction in SheepAnesthesiology, 1991
- Use of the postductal PaO2 as a predictor of pulmonary vascular hypoplasia in infants with congenital diaphragmatic herniaJournal of Pediatric Surgery, 1988
- Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factorNature, 1987
- Extracorporeal Membrane Oxygenation (ECMO) in Neonatal Respiratory FailureAnnals of Surgery, 1986
- Effects of PEEP and tolazoline infusion on respiratory and inert gas exchange in experimental meconium aspirationThe Journal of Pediatrics, 1982
- The independent effects of hyperventilation, tolazoline, and dopamine on infants with persistent pulmonary hypertensionThe Journal of Pediatrics, 1981
- Refractory hypoxemia associated with neonatal pulmonary disease: The use and limitations of tolazolineThe Journal of Pediatrics, 1979